Biocardia reports first quarter 2020 financial results and business highlights

San carlos, calif., may 15, 2020 (globe newswire) -- biocardia®, inc.  [nasdaq: bcda], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and business highlights for the first quarter of 2020 and filed its quarterly report on form 10-q for the three months ended march 31, 2020 with the securities and exchange commission on may 15, 2020.
BCDA Ratings Summary
BCDA Quant Ranking